KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strategy (MSTR) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Strategy (MSTR) over the last 16 years, with Q3 2025 value amounting to $2.8 million.

  • Strategy's Capital Expenditures rose 55657.28% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.9 million, marking a year-over-year increase of 16017.76%. This contributed to the annual value of $3.0 million for FY2024, which is 136.15% up from last year.
  • Per Strategy's latest filing, its Capital Expenditures stood at $2.8 million for Q3 2025, which was up 55657.28% from $2.1 million recorded in Q2 2025.
  • In the past 5 years, Strategy's Capital Expenditures ranged from a high of $2.8 million in Q3 2025 and a low of $284000.0 during Q4 2024
  • Moreover, its 5-year median value for Capital Expenditures was $641000.0 (2022), whereas its average is $986105.3.
  • Per our database at Business Quant, Strategy's Capital Expenditures plummeted by 7068.13% in 2024 and then skyrocketed by 55657.28% in 2025.
  • Quarter analysis of 5 years shows Strategy's Capital Expenditures stood at $824000.0 in 2021, then decreased by 22.94% to $635000.0 in 2022, then crashed by 45.35% to $347000.0 in 2023, then fell by 18.16% to $284000.0 in 2024, then soared by 884.86% to $2.8 million in 2025.
  • Its Capital Expenditures was $2.8 million in Q3 2025, compared to $2.1 million in Q2 2025 and $2.7 million in Q1 2025.